These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24191259)

  • 1. Studies on the role of metabolic activation in tyrosine kinase inhibitor-dependent hepatotoxicity: induction of CYP3A4 enhances the cytotoxicity of lapatinib in HepaRG cells.
    Hardy KD; Wahlin MD; Papageorgiou I; Unadkat JD; Rettie AE; Nelson SD
    Drug Metab Dispos; 2014 Jan; 42(1):162-71. PubMed ID: 24191259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 3A4 and CYP3A5-Catalyzed Bioactivation of Lapatinib.
    Towles JK; Clark RN; Wahlin MD; Uttamsingh V; Rettie AE; Jackson KD
    Drug Metab Dispos; 2016 Oct; 44(10):1584-97. PubMed ID: 27450182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interindividual Variation in CYP3A Activity Influences Lapatinib Bioactivation.
    Bissada JE; Truong V; Abouda AA; Wines KJ; Crouch RD; Jackson KD
    Drug Metab Dispos; 2019 Nov; 47(11):1257-1269. PubMed ID: 31492693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence.
    Teo YL; Saetaew M; Chanthawong S; Yap YS; Chan EC; Ho HK; Chan A
    Breast Cancer Res Treat; 2012 Jun; 133(2):703-11. PubMed ID: 22370628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detoxication versus Bioactivation Pathways of Lapatinib In Vitro: UGT1A1 Catalyzes the Hepatic Glucuronidation of Debenzylated Lapatinib.
    Nardone-White DT; Bissada JE; Abouda AA; Jackson KD
    Drug Metab Dispos; 2021 Mar; 49(3):233-244. PubMed ID: 33376146
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
    Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
    J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib.
    Teng WC; Oh JW; New LS; Wahlin MD; Nelson SD; Ho HK; Chan EC
    Mol Pharmacol; 2010 Oct; 78(4):693-703. PubMed ID: 20624855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of lapatinib with cytochrome P450 3A5.
    Chan EC; New LS; Chua TB; Yap CW; Ho HK; Nelson SD
    Drug Metab Dispos; 2012 Jul; 40(7):1414-22. PubMed ID: 22511346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.
    Chen S; Li X; Li Y; He X; Bryant M; Qin X; Li F; Seo JE; Guo X; Mei N; Guo L
    Toxicol Sci; 2023 Dec; 197(1):69-78. PubMed ID: 37788138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of safrole in HepaRG cells: studies on the role of CYP1A2-mediated ortho-quinone metabolic activation.
    Hu L; Wu F; He J; Zhong L; Song Y; Shao H
    Xenobiotica; 2019 Dec; 49(12):1504-1515. PubMed ID: 30865484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib.
    Takakusa H; Wahlin MD; Zhao C; Hanson KL; New LS; Chan EC; Nelson SD
    Drug Metab Dispos; 2011 Jun; 39(6):1022-30. PubMed ID: 21363997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of CYP3A4 inhibition and hepatotoxicity using DMSO-treated human hepatoma HuH-7 cells.
    Liu Y; Flynn TJ; Xia M; Wiesenfeld PL; Ferguson MS
    Cell Biol Toxicol; 2015 Oct; 31(4-5):221-30. PubMed ID: 26377104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular toxicity of clopidogrel: mechanisms and risk factors.
    Zahno A; Bouitbir J; Maseneni S; Lindinger PW; Brecht K; Krähenbühl S
    Free Radic Biol Med; 2013 Dec; 65():208-216. PubMed ID: 23770199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P450 3A-Catalyzed O-Dealkylation of Lapatinib Induces Mitochondrial Stress and Activates Nrf2.
    Eno MR; El-Gendy Bel-D; Cameron MD
    Chem Res Toxicol; 2016 May; 29(5):784-96. PubMed ID: 26958860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.
    Jiang LL; Jiang Y; Zhao DS; Fan YX; Yu Q; Li P; Li HJ
    Chem Res Toxicol; 2018 Oct; 31(10):1052-1060. PubMed ID: 30203651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
    Wen B; Chen Y; Fitch WL
    Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism-dependent inhibition of CYP3A4 by lapatinib: evidence for formation of a metabolic intermediate complex with a nitroso/oxime metabolite formed via a nitrone intermediate.
    Barbara JE; Kazmi F; Parkinson A; Buckley DB
    Drug Metab Dispos; 2013 May; 41(5):1012-22. PubMed ID: 23404373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative Evaluation of Cytochrome P450 3A4 Inhibition and Hepatotoxicity in HepaRG 3-D Spheroids.
    Shin DS; Seo H; Yang JY; Joo J; Im SH; Kim SS; Kim SK; Bae MA
    Int J Toxicol; 2018; 37(5):393-403. PubMed ID: 29923436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of components and mechanisms of Polygoni Multiflori Radix-induced hepatotoxicity using siRNA -mediated CYP3A4 or UGT1A1 knockdown liver cells.
    Hu YH; Li DK; Quan ZY; Wang CY; Zhou M; Sun ZX
    J Ethnopharmacol; 2021 Apr; 270():113845. PubMed ID: 33485974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interindividual Variability in Cytochrome P450 3A and 1A Activity Influences Sunitinib Metabolism and Bioactivation.
    Burnham EA; Abouda AA; Bissada JE; Nardone-White DT; Beers JL; Lee J; Vergne MJ; Jackson KD
    Chem Res Toxicol; 2022 May; 35(5):792-806. PubMed ID: 35484684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.